Skip to main content
ImmuneCited

Mô tả

In vivo diabetic wound healing data showing the progression of wound closure in liraglutide-treated versus untreated diabetic animals. Wound area measurements over time demonstrate accelerated healing in the treatment group.

Figure 3

Photograph

Source Paper

Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.

Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)

PMID: 39159301

DOI: 10.1002/advs.202405987

Cite This Figure

![Figure 3: In vivo diabetic wound healing data showing the progression of wound closure in liraglutide-treated versus untreated diabetic animals. Wound area measurements over time demonstrate accelerated healing in the treatment group.]()

> Source: Qian Zhang et al. "Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.." *Advanced science (Weinheim, Baden-Wurttemberg, Germany)*, 2024. PMID: [39159301](https://pubmed.ncbi.nlm.nih.gov/39159301/)
<figure>
  <img src="" alt="In vivo diabetic wound healing data showing the progression of wound closure in liraglutide-treated versus untreated diabetic animals. Wound area measurements over time demonstrate accelerated healing in the treatment group." />
  <figcaption>Figure 3. In vivo diabetic wound healing data showing the progression of wound closure in liraglutide-treated versus untreated diabetic animals. Wound area measurements over time demonstrate accelerated healing in the treatment group.<br>  Source: Qian Zhang et al. "Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.." <em>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39159301/">39159301</a></figcaption>
</figure>